BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21619592)

  • 1. Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.
    Burlina AP; Sims KB; Politei JM; Bennett GJ; Baron R; Sommer C; Møller AT; Hilz MJ
    BMC Neurol; 2011 May; 11():61. PubMed ID: 21619592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness of Fabry disease among rheumatologists--current status and perspectives.
    Cimaz R; Guillaume S; Hilz MJ; Horneff G; Manger B; Thorne JC; Møller AT; Wulffraat NM; Roth J
    Clin Rheumatol; 2011 Apr; 30(4):467-75. PubMed ID: 20393867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological complications of Anderson-Fabry disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
    Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of small nerve fiber involvement in the early diagnosis and treatment of patients with Fabry disease.
    Kokotis P; Zompola C; Anastasakis A; Damianaki A; Bountziouka C; Mpora M; Papatheodorou S; Tsivgoulis G
    J Neurol Sci; 2023 Oct; 453():120776. PubMed ID: 37797349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabry disease.
    Toyooka K
    Handb Clin Neurol; 2013; 115():629-42. PubMed ID: 23931807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel.
    Stepien KM; Broomfield A; Cole D; Deegan PB; Forshaw-Hulme S; Hughes D; Jovanovic A; Morris L; Muir A; Ramaswami U
    Orphanet J Rare Dis; 2023 Jul; 18(1):203. PubMed ID: 37480023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of small fiber neuropathy with pain intensity and age in patients with Fabry's disease: A cross sectional study within a large Taiwanese family.
    Liao MF; Hsu JL; Fung HC; Kuo HC; Chu CC; Chang HS; Lyu RK; Ro LS
    Biomed J; 2022 Apr; 45(2):406-413. PubMed ID: 35595648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological manifestations of Fabry disease].
    Mendióroz M; Fernández-Cadenas I; Montaner J
    Rev Neurol; 2006 Dec 16-31; 43(12):739-45. PubMed ID: 17160925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological complications in Fabry disease.
    Dütsch M; Hilz MJ
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S243-50. PubMed ID: 21211673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabry disease: a rare cause of neuropathic pain.
    Biegstraaten M; Linthorst GE; van Schaik IN; Hollak CE
    Curr Pain Headache Rep; 2013 Oct; 17(10):365. PubMed ID: 23996721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small fiber dysfunction predominates in Fabry neuropathy.
    Dütsch M; Marthol H; Stemper B; Brys M; Haendl T; Hilz MJ
    J Clin Neurophysiol; 2002 Dec; 19(6):575-86. PubMed ID: 12488789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment.
    Politei JM; Bouhassira D; Germain DP; Goizet C; Guerrero-Sola A; Hilz MJ; Hutton EJ; Karaa A; Liguori R; Üçeyler N; Zeltzer LK; Burlina A
    CNS Neurosci Ther; 2016 Jul; 22(7):568-76. PubMed ID: 27297686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy.
    Schiffmann R
    Acta Neurol Belg; 2006 Jun; 106(2):61-5. PubMed ID: 16898255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fabry disease : diagnosis and treatment].
    Üçeyler N; Sommer C
    Schmerz; 2012 Sep; 26(5):609-19. PubMed ID: 23052995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy.
    Hilz MJ; Brys M; Marthol H; Stemper B; Dütsch M
    Neurology; 2004 Apr; 62(7):1066-72. PubMed ID: 15079003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.
    Schiffmann R; Floeter MK; Dambrosia JM; Gupta S; Moore DF; Sharabi Y; Khurana RK; Brady RO
    Muscle Nerve; 2003 Dec; 28(6):703-10. PubMed ID: 14639584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small fiber neuropathy in Fabry disease.
    Biegstraaten M; Hollak CE; Bakkers M; Faber CG; Aerts JM; van Schaik IN
    Mol Genet Metab; 2012 Jun; 106(2):135-41. PubMed ID: 22497776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG; Ferraz MJ; Rodrigues D; Pais-Vieira M; Lima D; Brady RO; Sousa MM; Sá-Miranda MC
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.